Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Open-label, Multicenter Study of ZW171 in Participants With Advanced or Metastatic Ovarian Cancer, Non-small Cell Lung Cancer (NSCLC), and Other Mesothelin Expressing Cancers

NCT06523803 is registered in ClinicalTrials.gov with Zymeworks BC Inc. as lead sponsor.

NCT NCT06523803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06523803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Open-label, Multicenter Study of ZW171 in Participants With Advanced or Metastatic Ovarian Cancer, Non-small Cell Lung Cancer (NSCLC), and Other Mesothelin Expressing Cancers
Lead sponsor
Zymeworks BC Inc.
Phase
Phase 1
Overall status
Terminated
Start date
September 30, 2024
Completion date
October 1, 2025
Enrollment
32 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

mesothelin-expressing advanced cancers